Metallothioneins as dynamic markers for brain disease in lysosomal disorders.
San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy; Neurogenomics Laboratory, Harvard Medical School and Brigham & Women's Hospital, Cambridge, MA, USA.
- Published Article
Annals of Neurology
Wiley (John Wiley & Sons)
- Publication Date
Jan 01, 2014
Metallothioneins are potential markers of neurologic disease processes and treatment response in LSDs.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 04/18/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/24242821